Antiplatelet and anticoagulant drugs do not affect visual acuity in the comparing bevacizumab to ranibizumab in age-related macular degeneration (BRAMD) trial

被引：0
|
作者：
Schauwvlieghe, A. M. E. [1 ]
Buitendijk, G. H. S. [1 ]
Dijkman, G. [1 ]
Hoyng, C. [1 ]
Hooymans, J. M. [1 ]
Verbraak, F. D. [1 ]
Vingerling, J. R. [1 ]
Claver, C. C. [1 ]
Schlingemann, R. O. [1 ]
机构：
[1] Acad Med Ctr, Amsterdam, Netherlands
来源：
ACTA OPHTHALMOLOGICA | 2017年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：22 / 23
页数：2
相关论文
共 50 条
  • [21] Intravitreal Ranibizumab for Patients with Neovascular Age-Related Macular Degeneration with Good Baseline Visual Acuity
    Kato, Aki
    Yasukawa, Tsutomu
    Suga, Keiji
    Hirano, Yoshio
    Nozaki, Miho
    Yoshida, Munenori
    Ogura, Yuichiro
    OPHTHALMOLOGICA, 2015, 233 (01) : 27 - 34
  • [22] A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration
    Krebs, Ilse
    Schmetterer, Leopold
    Boltz, Agnes
    Told, Reinhard
    Vecsei-Marlovits, Veronika
    Egger, Stefan
    Schoenherr, Ulrich
    Haas, Anton
    Ansari-Shahrezaei, Siamak
    Binder, Susanne
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (03) : 266 - 271
  • [23] Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
    Chakravarthy, Usha
    Harding, Simon P.
    Rogers, Chris A.
    Downes, Susan M.
    Lotery, Andrew J.
    Wordsworth, Sarah
    Reeves, Barnaby C.
    OPHTHALMOLOGY, 2012, 119 (07)
  • [24] Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration
    Gamulescu M.-A.
    Radeck V.
    Lustinger B.
    Bianca Fink B.
    Helbig H.
    International Ophthalmology, 2010, 30 (3) : 261 - 266
  • [25] Ranibizumab versus bevacizumab for the treatment of neovascular age-related macular degeneration
    Abouammoh, Marwan
    Sharma, Sanjay
    CURRENT OPINION IN OPHTHALMOLOGY, 2011, 22 (03) : 152 - 158
  • [26] Pharmacogenetics of the Treatment Response of Age-Related Macular Degeneration with Ranibizumab and Bevacizumab
    Kanoff, Justin
    Miller, Joan
    SEMINARS IN OPHTHALMOLOGY, 2013, 28 (5-6) : 355 - 360
  • [27] Ranibizumab for Age-Related Macular Degeneration
    Trempe, Clement
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (06): : 581 - 582
  • [28] Ranibizumab for Age-related Macular Degeneration
    Seider, Michael I.
    Stewart, Jay M.
    OPHTHALMOLOGY, 2011, 118 (08) : 1693 - 1694
  • [29] Ranibizumab for age-related macular degeneration
    Dhoot, Dilsher S.
    Kaiser, Peter K.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (03) : 371 - 381
  • [30] Bevacizumab Injection in Patients with Age-Related Macular Degeneration Associated with Poor Initial Visual Acuity
    El Matri, Leila
    Bouraoui, Rym
    Chebil, Ahmed
    Kort, Fedra
    Bouladi, Mejda
    Limaiem, Rym
    Landoulsi, Hana
    JOURNAL OF OPHTHALMOLOGY, 2012, 2012
12345